Global Droxidopa Market Research Report 2024

Publication ID:

PB505247901

Publication Date:

May 22, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Specialty Chemicals [2]

Manufacturing (Chemicals) [3]

Chemicals [4]

Description:

Droxidopa is a prodrug of norepinephrine used to increase the concentrations of these neurotransmitters in the body and brain. It is metabolized by aromatic L-amino acid decarboxylase (AAAD), also known as DOPA decarboxylase (DDC). Patients with NOH have depleted levels of norepinephrine which leads to decreased blood pressure or hypotension upon orthostatic challenge.[6] Droxidopa works by increasing the levels of norepinephrine in the peripheral nervous system (PNS), thus enabling the body to maintain blood flow upon and while standing. Droxidopa can also cross the blood鈥揵rain barrier (BBB) where it is converted to norepinephrine from within the brain. Increased levels of norepinephrine in the central nervous system (CNS) may be beneficial to patients in a wide range of indications. Droxidopa can be coupled with a peripheral aromatic L-amino acid decarboxylase inhibitor (AAADI) or DOPA decarboxylase inhibitor (DDC) such as carbidopa (Lodosyn) to increase central norepinephrine concentrations while minimizing increases of peripheral levels.
The global Droxidopa market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Droxidopa is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Droxidopa is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Droxidopa include Piramal Enterprises Limited, Lupin Ltd, Sun Pharmaceutical Industries Ltd., Clarochem Ireland, Estechpharma Co., Ltd., Chongqing Shenghuaxi Pharm Co.,Ltd. and JINLAN Pharm-Drugs Technology Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Droxidopa, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Droxidopa.
Report Scope
The Droxidopa market size, estimations, and forecasts are provided in terms of output/shipments (Ton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Droxidopa market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Droxidopa manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Piramal Enterprises Limited
Lupin Ltd
Sun Pharmaceutical Industries Ltd.
Clarochem Ireland
Estechpharma Co., Ltd.
Chongqing Shenghuaxi Pharm Co.,Ltd.
JINLAN Pharm-Drugs Technology Co., Ltd.
Segment by Type
笔耻谤颈迟测鈮�98%
Purity<98%
Segment by Application
Droxidopa Tablets
Droxidopa Capsules
Others
Production by Region
Europe
China
India
South Korea
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Droxidopa manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Droxidopa by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Droxidopa in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Droxidopa Market Overview
1.1 Product Definition
1.2 Droxidopa Segment by Type
1.2.1 Global Droxidopa Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 笔耻谤颈迟测鈮�98%
1.2.3 Purity<98%
1.3 Droxidopa Segment by Application
1.3.1 Global Droxidopa Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Droxidopa Tablets
1.3.3 Droxidopa Capsules
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Droxidopa Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Droxidopa Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Droxidopa Production Estimates and Forecasts (2019-2030)
1.4.4 Global Droxidopa Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Droxidopa Production Market Share by Manufacturers (2019-2024)
2.2 Global Droxidopa Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Droxidopa, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Droxidopa Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Droxidopa Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Droxidopa, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Droxidopa, Product Offered and Application
2.8 Global Key Manufacturers of Droxidopa, Date of Enter into This Industry
2.9 Droxidopa Market Competitive Situation and Trends
2.9.1 Droxidopa Market Concentration Rate
2.9.2 Global 5 and 10 Largest Droxidopa Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Droxidopa Production by Region
3.1 Global Droxidopa Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Droxidopa Production Value by Region (2019-2030)
3.2.1 Global Droxidopa Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Droxidopa by Region (2025-2030)
3.3 Global Droxidopa Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Droxidopa Production by Region (2019-2030)
3.4.1 Global Droxidopa Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Droxidopa by Region (2025-2030)
3.5 Global Droxidopa Market Price Analysis by Region (2019-2024)
3.6 Global Droxidopa Production and Value, Year-over-Year Growth
3.6.1 Europe Droxidopa Production Value Estimates and Forecasts (2019-2030)
3.6.2 China Droxidopa Production Value Estimates and Forecasts (2019-2030)
3.6.3 India Droxidopa Production Value Estimates and Forecasts (2019-2030)
3.6.4 South Korea Droxidopa Production Value Estimates and Forecasts (2019-2030)
4 Droxidopa Consumption by Region
4.1 Global Droxidopa Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Droxidopa Consumption by Region (2019-2030)
4.2.1 Global Droxidopa Consumption by Region (2019-2024)
4.2.2 Global Droxidopa Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Droxidopa Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Droxidopa Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Droxidopa Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Droxidopa Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Droxidopa Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Droxidopa Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Droxidopa Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Droxidopa Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Droxidopa Production by Type (2019-2030)
5.1.1 Global Droxidopa Production by Type (2019-2024)
5.1.2 Global Droxidopa Production by Type (2025-2030)
5.1.3 Global Droxidopa Production Market Share by Type (2019-2030)
5.2 Global Droxidopa Production Value by Type (2019-2030)
5.2.1 Global Droxidopa Production Value by Type (2019-2024)
5.2.2 Global Droxidopa Production Value by Type (2025-2030)
5.2.3 Global Droxidopa Production Value Market Share by Type (2019-2030)
5.3 Global Droxidopa Price by Type (2019-2030)
6 Segment by Application
6.1 Global Droxidopa Production by Application (2019-2030)
6.1.1 Global Droxidopa Production by Application (2019-2024)
6.1.2 Global Droxidopa Production by Application (2025-2030)
6.1.3 Global Droxidopa Production Market Share by Application (2019-2030)
6.2 Global Droxidopa Production Value by Application (2019-2030)
6.2.1 Global Droxidopa Production Value by Application (2019-2024)
6.2.2 Global Droxidopa Production Value by Application (2025-2030)
6.2.3 Global Droxidopa Production Value Market Share by Application (2019-2030)
6.3 Global Droxidopa Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Piramal Enterprises Limited
7.1.1 Piramal Enterprises Limited Droxidopa Corporation Information
7.1.2 Piramal Enterprises Limited Droxidopa Product Portfolio
7.1.3 Piramal Enterprises Limited Droxidopa Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Piramal Enterprises Limited Main Business and Markets Served
7.1.5 Piramal Enterprises Limited Recent Developments/Updates
7.2 Lupin Ltd
7.2.1 Lupin Ltd Droxidopa Corporation Information
7.2.2 Lupin Ltd Droxidopa Product Portfolio
7.2.3 Lupin Ltd Droxidopa Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Lupin Ltd Main Business and Markets Served
7.2.5 Lupin Ltd Recent Developments/Updates
7.3 Sun Pharmaceutical Industries Ltd.
7.3.1 Sun Pharmaceutical Industries Ltd. Droxidopa Corporation Information
7.3.2 Sun Pharmaceutical Industries Ltd. Droxidopa Product Portfolio
7.3.3 Sun Pharmaceutical Industries Ltd. Droxidopa Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Sun Pharmaceutical Industries Ltd. Main Business and Markets Served
7.3.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7.4 Clarochem Ireland
7.4.1 Clarochem Ireland Droxidopa Corporation Information
7.4.2 Clarochem Ireland Droxidopa Product Portfolio
7.4.3 Clarochem Ireland Droxidopa Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Clarochem Ireland Main Business and Markets Served
7.4.5 Clarochem Ireland Recent Developments/Updates
7.5 Estechpharma Co., Ltd.
7.5.1 Estechpharma Co., Ltd. Droxidopa Corporation Information
7.5.2 Estechpharma Co., Ltd. Droxidopa Product Portfolio
7.5.3 Estechpharma Co., Ltd. Droxidopa Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Estechpharma Co., Ltd. Main Business and Markets Served
7.5.5 Estechpharma Co., Ltd. Recent Developments/Updates
7.6 Chongqing Shenghuaxi Pharm Co.,Ltd.
7.6.1 Chongqing Shenghuaxi Pharm Co.,Ltd. Droxidopa Corporation Information
7.6.2 Chongqing Shenghuaxi Pharm Co.,Ltd. Droxidopa Product Portfolio
7.6.3 Chongqing Shenghuaxi Pharm Co.,Ltd. Droxidopa Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Chongqing Shenghuaxi Pharm Co.,Ltd. Main Business and Markets Served
7.6.5 Chongqing Shenghuaxi Pharm Co.,Ltd. Recent Developments/Updates
7.7 JINLAN Pharm-Drugs Technology Co., Ltd.
7.7.1 JINLAN Pharm-Drugs Technology Co., Ltd. Droxidopa Corporation Information
7.7.2 JINLAN Pharm-Drugs Technology Co., Ltd. Droxidopa Product Portfolio
7.7.3 JINLAN Pharm-Drugs Technology Co., Ltd. Droxidopa Production, Value, Price and Gross Margin (2019-2024)
7.7.4 JINLAN Pharm-Drugs Technology Co., Ltd. Main Business and Markets Served
7.7.5 JINLAN Pharm-Drugs Technology Co., Ltd. Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Droxidopa Industry Chain Analysis
8.2 Droxidopa Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Droxidopa Production Mode & Process
8.4 Droxidopa Sales and Marketing
8.4.1 Droxidopa Sales Channels
8.4.2 Droxidopa Distributors
8.5 Droxidopa Customers
9 Droxidopa Market Dynamics
9.1 Droxidopa Industry Trends
9.2 Droxidopa Market Drivers
9.3 Droxidopa Market Challenges
9.4 Droxidopa Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer

Companies Mentioned:

Piramal Enterprises Limited
Lupin Ltd
Sun Pharmaceutical Industries Ltd.
Clarochem Ireland
Estechpharma Co., Ltd.
Chongqing Shenghuaxi Pharm Co.,Ltd.
JINLAN Pharm-Drugs Technology Co., Ltd.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂